Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

Market Cap	797.53M -24.8%
Revenue (ttm)	76.50M -90.0%
Net Income	-184.83M
EPS	-4.28
Shares Out	43.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,588
Average Volume	36,973
Open	18.35
Previous Close	18.82
Day's Range	18.18 - 18.74
52-Week Range	16.55 - 28.80
Beta	0.22
RSI	44.92
Earnings Date	Oct 31, 2025

About BOM:524663

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1989
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524663

Financial Performance

In fiscal year 2023, BOM:524663's revenue was 446.09 million, a decrease of -43.09% compared to the previous year's 783.88 million. Losses were -166.39 million, 90.1% more than in 2022.